Innovation in this space depends on strategizing for GMP compliance and market access.
Patrick Thiaville
Advertisement
Patrick Thiavilleis chief technology officer of Exothera.
Articles by Patrick Thiaville
Advertisement
Latest Updated Articles
Driving Innovation in Nucleic Acid TherapeuticsApril 1st 2024
Advertisement
Advertisement